Ramiro Andrei Ramirez-Valdez

Ramiro Andrei Ramirez-Valdez

Company: Vaccitech

Job title: Post-Doctoral Scientist

Seminars:

Panel Discussion: How can biotechs best leverage partnerships early on in drug development to ensure cancer vaccine success? 11:45 am

Assessing the importance of bringing in the right staff from the field Developing the science and the story in early development to attract potential partners, when you don’t have clinical data available Attributes of a perfect partnership Types of partnerships (in/out licensing of product, financing of clinical trial, providing comparator drug, etc.) Key partnerships crucial…Read more

day: Day Two

Leveraging innate and adaptive mechanisms of anticancer immunity with IV heterologous vaccination 1:45 pm

SNAPvaxTM is a self-assembling nanoparticle codelivering TLR-7/8a and cancer antigens ChAdOx is an adenovirus that can be programmed to encode cancer antigens and has been demonstrated to be safe and effective for inducing T cell immunity in patients Intravenous heterologous prime boost with SNAPvax and ChAdOx results in improved tumor clearance in preclinical animal models…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.